• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Liver transplantation for hepatocellular carcinoma: pushing the boundaries.

作者信息

O'Rourke Joanne M, Shetty Shishir, Shah Tahir, Perera M Thamara P R

机构信息

Liver Unit, Queen Elizabeth Hospital, Birmingham, UK.

出版信息

Transl Gastroenterol Hepatol. 2019 Jan 2;4:1. doi: 10.21037/tgh.2018.12.07. eCollection 2019.

DOI:10.21037/tgh.2018.12.07
PMID:30854488
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6378266/
Abstract
摘要

相似文献

1
Liver transplantation for hepatocellular carcinoma: pushing the boundaries.肝细胞癌的肝移植：突破界限
Transl Gastroenterol Hepatol. 2019 Jan 2;4:1. doi: 10.21037/tgh.2018.12.07. eCollection 2019.
2
Pushing the limits of surgical management in patients with hepatocellular carcinoma.突破肝细胞癌患者手术治疗的极限。
Br J Surg. 2011 Sep;98(9):1183-4. doi: 10.1002/bjs.7677.
3
Liver transplantation for unresectable malignancies: Beyond hepatocellular carcinoma.肝脏移植治疗不可切除的恶性肿瘤：超越肝细胞癌。
Eur J Surg Oncol. 2019 Dec;45(12):2268-2278. doi: 10.1016/j.ejso.2019.07.024. Epub 2019 Jul 24.
4
Liver transplantation for hepatocellular carcinoma.肝细胞癌的肝移植
Hepatogastroenterology. 2002 Jan-Feb;49(43):47-52.
5
[Liver transplantation for hepatocellular carcinoma and potential application of PSI].[肝细胞癌的肝移植及PSI的潜在应用]
Gastroenterol Clin Biol. 2009 Nov;33 Suppl 4:S257-62. doi: 10.1016/S0399-8320(09)73163-X.
6
Living Donor Liver Transplantation for Combined Hepatocellular Carcinoma and Cholangiocarcinoma: Experience of a Single Center.活体供肝肝移植治疗肝细胞癌合并胆管癌：单中心经验
Ann Transplant. 2017 Feb 28;22:115-120. doi: 10.12659/aot.900779.
7
Development and validation of the HALT-HCC score to predict mortality in liver transplant recipients with hepatocellular carcinoma: a retrospective cohort analysis.HALT-HCC 评分的开发和验证：用于预测肝癌肝移植受者死亡率的回顾性队列分析。
Lancet Gastroenterol Hepatol. 2017 Aug;2(8):595-603. doi: 10.1016/S2468-1253(17)30106-1. Epub 2017 May 22.
8
[Results of liver transplantation in patients with hepatocellular carcinoma].[肝细胞癌患者肝移植的结果]
Arq Gastroenterol. 2001 Oct-Dec;38(4):216-20. doi: 10.1590/s0004-28032001000400002.
9
Laparoscopic staging and radiofrequency of hepatocellular carcinoma in liver ci rrhosis. A "bridge" treatment to liver transplantation.肝硬化患者肝细胞癌的腹腔镜分期及射频治疗。肝移植的“桥梁”治疗。
Hepatogastroenterology. 2009 May-Jun;56(91-92):793-7.
10
[Hepatic resection and transplantation for hepatocellular carcinoma in patients with cirrhosis].[肝硬化患者肝细胞癌的肝切除与肝移植]
Gastroenterol Clin Biol. 1997;21(8-9):590-5.

引用本文的文献

1
Immune Checkpoint Inhibitors in the Pre-Transplant Hepatocellular Carcinoma Setting: A Glimpse Beyond the Liver.免疫检查点抑制剂在移植前肝细胞癌治疗中的应用：肝脏之外的探索。
Int J Mol Sci. 2024 Oct 30;25(21):11676. doi: 10.3390/ijms252111676.
2
Transcription factor glucocorticoid modulatory element-binding protein 1 promotes hepatocellular carcinoma progression by activating Yes-associate protein 1.转录因子糖皮质激素调节元件结合蛋白1通过激活Yes相关蛋白1促进肝细胞癌进展。
World J Gastrointest Oncol. 2023 Jun 15;15(6):988-1004. doi: 10.4251/wjgo.v15.i6.988.
3
Are the criteria always right? Assessment of hepatocellular carcinoma cases in living donor liver transplantation at a high-volume center.标准是否总是正确的？在高容量中心对活体肝移植中的肝细胞肝癌病例进行评估。
Turk J Med Sci. 2021 Oct 21;51(5):2383-2395. doi: 10.3906/sag-2101-51.
4
Intratumoral IL-12 Gene Therapy Inhibits Tumor Growth In A HCC-Hu-PBL-NOD/SCID Murine Model.瘤内白细胞介素-12基因治疗在肝癌-人外周血淋巴细胞-非肥胖型糖尿病/严重联合免疫缺陷小鼠模型中抑制肿瘤生长
Onco Targets Ther. 2019 Sep 20;12:7773-7784. doi: 10.2147/OTT.S222097. eCollection 2019.

本文引用的文献

1
Is it Time to Abandon the Milan Criteria?: Results of a Bicoastal US Collaboration to Redefine Hepatocellular Carcinoma Liver Transplantation Selection Policies.是否到了放弃米兰标准的时候了？：美国东西两岸合作重新定义肝细胞癌肝移植选择政策的结果。
Ann Surg. 2018 Oct;268(4):690-699. doi: 10.1097/SLA.0000000000002964.
2
Prognostic role of alpha-fetoprotein response after hepatocellular carcinoma resection.肝细胞癌切除术后甲胎蛋白反应的预后作用
World J Clin Cases. 2018 Jun 16;6(6):110-120. doi: 10.12998/wjcc.v6.i6.110.
3
Impact of remnant vital tissue after locoregional treatment and liver transplant in hepatocellular cancer patients, a multicentre cohort study.局部区域治疗和肝移植后残留重要组织对肝细胞癌患者的影响：一项多中心队列研究
Transpl Int. 2018 Mar 23. doi: 10.1111/tri.13153.
4
Viability testing and transplantation of marginal livers (VITTAL) using normothermic machine perfusion: study protocol for an open-label, non-randomised, prospective, single-arm trial.使用常温机器灌注进行边缘性肝脏的活力测试与移植（VITTAL）：一项开放标签、非随机、前瞻性、单臂试验的研究方案
BMJ Open. 2017 Nov 28;7(11):e017733. doi: 10.1136/bmjopen-2017-017733.
5
Radiological response and inflammation scores predict tumour recurrence in patients treated with transarterial chemoembolization before liver transplantation.经动脉化疗栓塞术治疗前行肝移植的患者，其放射学反应和炎症评分可预测肿瘤复发。
World J Gastroenterol. 2017 May 28;23(20):3690-3701. doi: 10.3748/wjg.v23.i20.3690.
6
Changes in serum α-fetoprotein level predicts treatment response and survival in hepatocellular carcinoma patients and literature review.血清甲胎蛋白水平的变化可预测肝癌患者的治疗反应和生存情况，并进行文献复习。
J Formos Med Assoc. 2018 Feb;117(2):153-163. doi: 10.1016/j.jfma.2017.03.010. Epub 2017 Apr 6.
7
Alpha-fetoprotein and (18)F-FDG positron emission tomography predict tumor recurrence better than Milan criteria in living donor liver transplantation.甲胎蛋白和 (18)F-FDG 正电子发射断层扫描比米兰标准更能预测活体供肝移植中的肿瘤复发。
J Hepatol. 2016 Apr;64(4):852-9. doi: 10.1016/j.jhep.2015.11.033. Epub 2015 Nov 30.
8
Total tumor volume and alpha-fetoprotein for selection of transplant candidates with hepatocellular carcinoma: A prospective validation.总肿瘤体积和甲胎蛋白联合用于选择肝癌肝移植候选者：前瞻性验证。
Hepatology. 2015 Jul;62(1):158-65. doi: 10.1002/hep.27787. Epub 2015 Apr 22.
9
Downstaging of hepatocellular cancer before liver transplant: long-term outcome compared to tumors within Milan criteria.肝移植前肝细胞癌降期：与米兰标准内肿瘤相比的长期预后
Hepatology. 2015 Jun;61(6):1968-77. doi: 10.1002/hep.27752. Epub 2015 Mar 20.
10
Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.全球癌症发病与死亡：GLOBOCAN 2012 数据源、方法与主要模式。
Int J Cancer. 2015 Mar 1;136(5):E359-86. doi: 10.1002/ijc.29210. Epub 2014 Oct 9.